204 related articles for article (PubMed ID: 16103203)
21. Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins.
Huthoff H; Malim MH
Virology; 2005 Apr; 334(2):147-53. PubMed ID: 15780864
[TBL] [Abstract][Full Text] [Related]
22. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.
Bogerd HP; Doehle BP; Wiegand HL; Cullen BR
Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3770-4. PubMed ID: 14999100
[TBL] [Abstract][Full Text] [Related]
23. Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort.
Do H; Vasilescu A; Diop G; Hirtzig T; Heath SC; Coulonges C; Rappaport J; Therwath A; Lathrop M; Matsuda F; Zagury JF
J Infect Dis; 2005 Jan; 191(2):159-63. PubMed ID: 15609224
[TBL] [Abstract][Full Text] [Related]
24. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
Peng G; Lei KJ; Jin W; Greenwell-Wild T; Wahl SM
J Exp Med; 2006 Jan; 203(1):41-6. PubMed ID: 16418394
[TBL] [Abstract][Full Text] [Related]
25. [The innate antiretroviral defense of human cells, based on the DNA editing].
Pupecka M; Pacak A
Postepy Biochem; 2006; 52(3):247-52. PubMed ID: 17201059
[TBL] [Abstract][Full Text] [Related]
26. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
Sheehy AM; Gaddis NC; Choi JD; Malim MH
Nature; 2002 Aug; 418(6898):646-50. PubMed ID: 12167863
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 Vif and APOBEC3G: multiple roads to one goal.
Goncalves J; Santa-Marta M
Retrovirology; 2004 Sep; 1():28. PubMed ID: 15383144
[TBL] [Abstract][Full Text] [Related]
28. Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation.
Ma L; Zhang Z; Liu Z; Pan Q; Wang J; Li X; Guo F; Liang C; Hu L; Zhou J; Cen S
Sci Rep; 2018 May; 8(1):8067. PubMed ID: 29795228
[TBL] [Abstract][Full Text] [Related]
29. T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent manner.
Vallanti G; Lupo R; Federico M; Mavilio F; Bovolenta C
Mol Ther; 2005 Oct; 12(4):697-706. PubMed ID: 16039909
[TBL] [Abstract][Full Text] [Related]
30. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
Chen K; Huang J; Zhang C; Huang S; Nunnari G; Wang FX; Tong X; Gao L; Nikisher K; Zhang H
J Virol; 2006 Aug; 80(15):7645-57. PubMed ID: 16840343
[TBL] [Abstract][Full Text] [Related]
31. APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon.
Armitage AE; Deforche K; Chang CH; Wee E; Kramer B; Welch JJ; Gerstoft J; Fugger L; McMichael A; Rambaut A; Iversen AK
PLoS Genet; 2012; 8(3):e1002550. PubMed ID: 22457633
[TBL] [Abstract][Full Text] [Related]
32. Functional domains of APOBEC3G required for antiviral activity.
Li J; Potash MJ; Volsky DJ
J Cell Biochem; 2004 Jun; 92(3):560-72. PubMed ID: 15156567
[TBL] [Abstract][Full Text] [Related]
33. New insights into the role of Vif in HIV-1 replication.
Schröfelbauer B; Yu Q; Landau NR
AIDS Rev; 2004; 6(1):34-9. PubMed ID: 15168739
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Vif-induced APOBEC3G degradation using an alpha-complementation assay.
Fang L; Landau NR
Virology; 2007 Mar; 359(1):162-9. PubMed ID: 17049578
[TBL] [Abstract][Full Text] [Related]
35. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.
Yu X; Yu Y; Liu B; Luo K; Kong W; Mao P; Yu XF
Science; 2003 Nov; 302(5647):1056-60. PubMed ID: 14564014
[TBL] [Abstract][Full Text] [Related]
36. Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation.
Zhang L; Saadatmand J; Li X; Guo F; Niu M; Jiang J; Kleiman L; Cen S
Virology; 2008 Jan; 370(1):113-21. PubMed ID: 17916373
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
Marin M; Rose KM; Kozak SL; Kabat D
Nat Med; 2003 Nov; 9(11):1398-403. PubMed ID: 14528301
[TBL] [Abstract][Full Text] [Related]
38. Recent insights into HIV-1 Vif.
Navarro F; Landau NR
Curr Opin Immunol; 2004 Aug; 16(4):477-82. PubMed ID: 15245742
[TBL] [Abstract][Full Text] [Related]
39. Host APOBEC3G protein inhibits HCV replication through direct binding at NS3.
Zhu YP; Peng ZG; Wu ZY; Li JR; Huang MH; Si SY; Jiang JD
PLoS One; 2015; 10(3):e0121608. PubMed ID: 25811715
[TBL] [Abstract][Full Text] [Related]
40. Protecting APOBEC3G: a potential new target for HIV drug discovery.
Stopak K; Greene WC
Curr Opin Investig Drugs; 2005 Feb; 6(2):141-7. PubMed ID: 15751736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
